EVERSANA

EVERSANA is a leading global provider of integrated commercialization services for the life sciences industry, serving pharmaceutical, biotech, and medical device companies. They offer end-to-end solutions across the product lifecycle, including market access, patient services, medical affairs, and digital transformation. EVERSANA leverages proprietary data, analytics, and AI-powered platforms, such as NAVLIN for global pricing and market access, and AI Agency Platform for marketing, to optimize commercial strategies, accelerate market entry, and enhance patient outcomes globally.

Audience members with pink lanyards attentively watching and smiling during a presentation.

Vendor Details

Advancing life sciences commercialization through integrated services, innovative technology, and AI-powered solutions.

Claim Profile
Claim Profile
Pillar
Marketing Strategy & Analysis
Primary SITech Category
Social Marketing Management
2nd SubCat
Customer Experience Management (CXM)
3rd SubCat
Customer Intelligence
Tech Category
AI, Machine Learning, Cloud-based Platforms, Data Analytics, Digital Transformation, Software
Data Coverage
Business & Firmographic (B2B) Data
Financial & Market Data
Healthcare & Medical Data
News & Editorial Media
Data Sources
Online News & Editorial Media
AI/GenAI Type
Predictive AI & Analytics
AI Agents & Automation
Geographic Coverage
Global / Worldwide
Specialized Industries
Healthcare & Life Sciences
Pharmaceutical
HQ Location
North America

Company Info

EVERSANA is a leading global provider of integrated commercialization services for the life sciences industry, serving pharmaceutical, biotech, and medical device companies. They offer end-to-end solutions across the product lifecycle, including market access, patient services, medical affairs, and digital transformation. EVERSANA leverages proprietary data, analytics, and AI-powered platforms, such as NAVLIN for global pricing and market access, and AI Agency Platform for marketing, to optimize commercial strategies, accelerate market entry, and enhance patient outcomes globally.